ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.63
0.12%
US Tech 100
21,156.80
-0.70%
S&P 500
6,101.24
-0.29%
US Dollar vs CAD
1.44878
0.00%
Bitcoin
104,573.33
-0.15%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Dr. Martens Plc (DOCS) Share Price

Dr. Martens Plc

Dr. Martens Plc (DOCS)

Doximity Inc
72.45
1.55
(2.19%)
Closed January 26 10:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
72.45
Bid
72.85
Ask
73.25
Volume
1,413,772
70.20 Day's Range 74.25
49.42 52 Week Range 99.65
Market Cap
698.65M
Previous Close
70.90
Open
70.20
Last Trade
29
@
72.9
(O)
Last Trade Time
Financial Volume
1,027,371p
VWAP
72.6688
Average Volume (3m)
1,974,701
Shares Outstanding
964,319,766
Dividend Yield
2.54%
PE Ratio
24.79
Earnings Per Share (EPS)
0.07
Revenue
877.1M
Net Profit
69.2M

About Dr. Martens Plc

Sector
Footwear-wholesale
Industry
Footwear-wholesale
Website
www.drmartensplc.com
Headquarters
London, Gbr
Founded
-
Dr. Martens Plc is listed in the Footwear-wholesale sector of the London Stock Exchange with ticker DOCS. The last closing price for Dr. Martens was 70.90p. Over the last year, Dr. Martens shares have traded in a share price range of 49.42p to 99.65p.

Dr. Martens currently has 964,319,766 shares outstanding. The market capitalization of Dr. Martens is £683.70 million. Dr. Martens has a price to earnings ratio (PE ratio) of 24.79.

Ask ADVFN Intelligence (AI)

DOCS Latest News

More News

Dr. Martens PLC Director/PDMR Shareholding

Dr. Martens PLC 15 January 2025   Dr. Martens plc (the 'Company') Director/PDMR Shareholding Notification of Transactions by Directors/Persons Discharging Managerial Responsibility The Company...

January 15 2025
RNS Regulatory News

Dr. Martens PLC Total Voting Rights

Dr. Martens PLC 02 January 2025   Dr. Martens plc (the "Company")   Total Voting Rights   The following information is released in accordance with the FCA's Disclosure Guidance and...

January 02 2025
RNS Regulatory News

Dr. Martens PLC Holding(s) in Company

Dr. Martens PLC 20 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BL6NGV24 Issuer Name DR. MARTENS PLC UK or Non-UK Issuer UK 2. Reason for...

December 20 2024
RNS Regulatory News

Dr. Martens PLC Director/PDMR Shareholding

Dr. Martens PLC 13 December 2024   Dr. Martens plc (the 'Company') Director/PDMR Shareholding Notification of Transactions by Directors/Persons Discharging Managerial Responsibility The...

December 13 2024
RNS Regulatory News

Dr. Martens PLC Block Listing Application

Dr. Martens PLC 12 December 2024   12 December 2024   Dr. Martens plc (the "Company") Block Listing application   The Company announces today that application has been made to the FCA and to...

December 12 2024
RNS Regulatory News

Dr. Martens PLC Block listing Interim Review

Dr. Martens PLC 02 December 2024   BLOCK LISTING SIX MONTHLY RETURN   Date: 2 DECEMBER 2024   Name of applicant: DR. MARTENS PLC Name of scheme: DR. MARTENS PLC'S EMPLOYEE SHARE PLANS Period...

December 02 2024
RNS Regulatory News

Dr. Martens PLC Total Voting Rights

Dr. Martens PLC 02 December 2024   Dr. Martens plc (the "Company")   Total Voting Rights   The following information is released in accordance with the FCA's Disclosure Guidance and...

December 02 2024
RNS Regulatory News

Dr. Martens PLC Confirmation of new CEO start date

Dr. Martens PLC 28 November 2024     28 November 2024 Dr. Martens plc ('Dr. Martens', 'the Company') Confirmation of new CEO start date   Further to the Company's previous announcement on 16...

November 28 2024
RNS Regulatory News

Dr. Martens PLC Half-year Report

Dr. Martens PLC 28 November 2024     28 November 2024 Dr. Martens plc First half results for the 26 weeks ended 29 September 2024   RESULTS IN LINE WITH EXPECTATIONS AND DELIVERING ON OUR...

November 28 2024
RNS Regulatory News

Dr. Martens PLC Director/PDMR Shareholding

Dr. Martens PLC 12 November 2024   Dr. Martens plc (the 'Company') Director/PDMR Shareholding Notification of Transactions by Directors/Persons Discharging Managerial Responsibility The...

November 12 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
15.68.3769633507966.8574.2566.8595268270.48453398DE
4-3.7-4.858831254176.15776594173570.29411892DE
1218.2533.671586715954.278.952.55197470167.34442772DE
262.453.57078.949.42205583662.3137074DE
52-4.6-5.9701492537377.0599.6549.42194277071.45843239DE
156-270.75-78.8898601399343.2343.249.422297356147.65242848DE
260-352.55-82.9529411765425521.649.422276675216.18824793DE

DOCS - Frequently Asked Questions (FAQ)

What is the current Dr. Martens share price?
The current share price of Dr. Martens is 72.45p
How many Dr. Martens shares are in issue?
Dr. Martens has 964,319,766 shares in issue
What is the market cap of Dr. Martens?
The market capitalisation of Dr. Martens is GBP 683.7M
What is the 1 year trading range for Dr. Martens share price?
Dr. Martens has traded in the range of 49.42p to 99.65p during the past year
What is the PE ratio of Dr. Martens?
The price to earnings ratio of Dr. Martens is 24.79
What is the cash to sales ratio of Dr. Martens?
The cash to sales ratio of Dr. Martens is 1.96
What is the reporting currency for Dr. Martens?
Dr. Martens reports financial results in GBP
What is the latest annual turnover for Dr. Martens?
The latest annual turnover of Dr. Martens is GBP 877.1M
What is the latest annual profit for Dr. Martens?
The latest annual profit of Dr. Martens is GBP 69.2M
What is the registered address of Dr. Martens?
The registered address for Dr. Martens is 28 JAMESTOWN ROAD, CAMDEN, LONDON, NW1 7BY
What is the Dr. Martens website address?
The website address for Dr. Martens is www.drmartensplc.com
Which industry sector does Dr. Martens operate in?
Dr. Martens operates in the FOOTWEAR-WHOLESALE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PPSProton Motor Power Systems Plc
0.325p
(85.71%)
4.07M
CTAICatenai Plc
0.255p
(34.21%)
79.48M
MILAMila Resources Plc
0.23p
(31.43%)
27.89M
SNGSynairgen Plc
2.34p
(26.66%)
6.36M
GILDGuild Esports Plc
0.05p
(25.00%)
34.84M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
EXREngage Xr Holdings Plc
1.55p
(-20.92%)
12.64M
RNWHRenew Holdings Plc
720.00p
(-20.79%)
2.45M
UKRUkrproduct Group Limited
2.00p
(-20.00%)
1.25k
PREMPremier African Minerals Limited
0.0245p
(-2.00%)
2.6B
TRPTower Resources Plc
0.0295p
(7.27%)
1.07B
EMEEmpyrean Energy Plc
0.1075p
(-23.21%)
305.19M
QEDQuadrise Plc
4.01p
(-31.10%)
213.11M
RRRRed Rock Resources Plc
0.0525p
(-4.55%)
198.76M

Discussion

View Full Feed
EZmoney- EZmoney- 2 minutes ago
T53 guess who's back !!!
Truthsocial Truthsocial 2 minutes ago
FO DF
RDGL
ChannelTrader ChannelTrader 3 minutes ago
That would solve the problem.
Golden Cross Golden Cross 3 minutes ago
💲 000 Stocks Can make You Rich!
Golden Cross Golden Cross 5 minutes ago
💲 000 Stocks Can make You Rich!
arizona1 arizona1 5 minutes ago
Trump Supporters Are Begging Him For Their Jobs Back

https://substackcdn.com/image/fetch/w_2250,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fe1724342-3fad-42ff-b838-435b57d6caad_1125x720.jpeg

http
janice shell janice shell 7 minutes ago
Yes, of course. Uqora. The story of the founder, Jenna Ryan, is probably familiar to a very large number of women. Symptoms can be sort of vague, and they can change, and they can be hard to describe to a doctor. I think some kind of regime like the one they suggest makes sense. They evidently have
StayHumble StayHumble 7 minutes ago
perForbes Insiders CE0💹KevinLamb💹+💹Bryan Cranston wow $UBQU

https://x.com/CorporateUbqu/status/1802724359762506049
https://x.com/I_Outcomes/status/1812870363094626701

".......believe it... i'm insider too ......"
https://cdn.vo
UBQU
igotthemojo igotthemojo 7 minutes ago
about what i expected...i think its time for your nap little boy...
PLUG
Gmenfan Gmenfan 8 minutes ago
How much are second hand parachutes? And I'm being kind here.....
igotthemojo igotthemojo 9 minutes ago
i told you the last time you made that comment about yarn that it was stupid...and then you repeated the same nonsense...

you were DEAD WRONG then and you are DEAD WRONG now...

"And yes, we know, "this time is different"."

FINALLY you have stated somethin
KBLB
ilovetech ilovetech 9 minutes ago
If I were the CEO of NWBO, I would SERIOUSLY consider the block chain dividend strategy, which Danish posted about on X. That is unless LP has decided to go with a merger, for example, with a company like Revimmune to register under a new CUSP number, where both strategies have successfully squeeze
NWBO
Airfred Airfred 9 minutes ago
Love the idea I’ll sign

Long time reader first time writing
FNMA
Pnypnchr Pnypnchr 11 minutes ago
This is ihub, that will never change me.
BLTHD
Investor2014 Investor2014 11 minutes ago
Exactly, a correlation to actual endpoints of the trial must be established.
It also has yet to be shown to be correlated with or causative of clinical outcomes.

From there further trials would be needed, where brain atrophy reduction is confirmed correlated to cognitive and/or
AVXL
MightyX MightyX 12 minutes ago
Your homies allow-you to f-bomb..good show for-the public
TPTW
georgejjl georgejjl 12 minutes ago
Pantheon and Syntagon combined give Anavex the production process control and capacity to produce Blarcamesine for commercialization and worldwide distribution and sales.

https://patheon.com/

https://www.syntegon.com/company

Good luck and GOD bless,
AVXL
PEACHMAN PEACHMAN 12 minutes ago
Plenty of accurate due diligence and news available at IFUS website

https://impactfusionbrands.com/news/

IFUS STRONG
IFUS
StayHumble StayHumble 13 minutes ago
Update!💹FundersWait✅2Ensure $DBMM Still Trades✅idiot💹

$DBMM has the Ability to move forward, to continue to grow its business, benefits its shareholders and asks that the Commission affirm the decision of the Law Judge denying revocation of its regis
DBMM GTII HPIL
SHEEPWOLF SHEEPWOLF 13 minutes ago
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR
SHEEPWOLF SHEEPWOLF 13 minutes ago
$ILLR TRILLER GROUP CEO WING FAI NG and Mario Lopez at #BKFC KM5
https://investorshub.advfn.com/uimage/uploads/2025/1/26/muhlpSmartSelect_20250126_154850_X.jpg
ILLR

Your Recent History

LSE
DOCS
Dr. Martens
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads